What Evivo does

Evivo, operated by Infinant Health, Inc. (incorporated in California), is a consumer biotechnology company that develops and sells a daily infant probiotic built around a single proprietary bacterial strain — Bifidobacterium longum subsp. infantis (B. infantis) EVC001. Founded in 2005 by five UC Davis scientists (Bruce German, Carlito Lebrilla, Daniela Barile, David Mills, Samara Freeman) who spent decades researching breast milk and the infant gut microbiome, Evivo's central scientific claim is that EVC001 is the only probiotic strain capable of fully digesting human milk oligosaccharides (HMOs) in breast milk, converting them into lactate and acetate that lower gut pH and create a protective environment. The product targets an addressable problem: approximately 90% of US babies are reported to lack B. infantis due to C-sections, antibiotics, and modern hygiene, leading to suboptimal HMO utilization, elevated gut pH, and downstream digestive/immune issues.

Evivo offers two delivery formats — Evivo Drops (liquid with olive oil and organic Vitamin D3) and Evivo Powder Packets (individually packaged single-day sachets) — both containing the same proprietary EVC001 strain and intended for newborns and infants fed any amount of breast milk or HMOs in formula. The company's moat rests on the proprietary strain itself plus 14+ published clinical studies, including the GPPAD SINT1A Trial (1,149 infants across Europe/UK, funded by the Helmsley Charitable Trust) and a Johnson & Johnson Consumer collaboration in Finland (270+ infants). Products are sold via a direct-to-consumer e-commerce storefront (store.evivo.com), Amazon, Walmart, specialty retailer Bumblebaby, and baby registries, with an auto-ship subscription program offering discounted pricing relative to one-time purchases. A Clinical Implementation team (including board-certified pediatricians and neonatologists) drives healthcare professional recommendations, complemented by community partnerships with lactation consultants, Doulas, and organizations such as SimpliFed.

The company is headquartered in Sacramento, California (2535 Capitol Oaks Dr., Suite 130), employs 51-100 people, holds Non-GMO Project Verification, Nutrasource IPRO certification, Mom's Choice Award recognition, and Clean Label Project Baby Coalition membership. Pricing is not publicly disclosed on the website; revenue, funding history, and detailed cap table are not disclosed in available sources. No AI/ML capabilities, APIs, or developer-facing integrations are evident in the product or technology stack.

Name

Evivo

Legal name

Infinant Health, Inc

Website

https://evivo.com

Company type

Private

Founded year

2005

Operating status

Operating

Headcount range

51–100 employees

Short description

Evivo (Infinant Health, Inc.) is a Sacramento-based consumer biotechnology company that sells a daily infant probiotic containing the proprietary B. infantis EVC001 strain, sold direct-to-consumer and through major retailers to parents of newborns, with clinical recommendations driven by pediatricians and lactation consultants.

Ownership category

akta.pro rank

Product category

Infant Probiotics

NAICS

Food Manufacturing (311)

SIC

Food And Kindred Products (2000)

akta.pro primary industry

Baby Feeding Supplements & Fortifiers (Probiotics, DHA/ARA, Vitamins) (CRADAEAI)

akta.pro secondary industry

Infant Formula & Specialized Dairy Nutrition Manufacturing (AFAKAKAJ)

Keywords

• Infant probiotic supplements
• Pediatric nutritional supplements
• Gut microbiome products
• Baby probiotic drops
• B. infantis probiotics

Headquarters

HQ city

Davis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Supply Chain, Marketing or Sales, Technology or R&D, Personnel

Revenue model

1. Evivo Infant Probiotic Products: Direct sales of infant probiotic products (drops and powder packets) through e-commerce and retail channels. Products are offered as one-time purchases or through subscription plans for recurring monthly shipments.
2. Subscription Service: Monthly subscription program with recurring billing, offering discounted pricing vs one-time purchases. Subscribers receive automatic monthly shipments until cancellation.

Go-to-market motion2 records

Distribution channels6 records

Marketing channels7 records

Core offering

Evivo (Infinant Health, Inc.) manufactures and sells daily infant probiotic products containing the proprietary Bifidobacterium longum subsp. infantis (B. infantis) EVC001 strain, available as liquid drops and powder packets. The products are designed to establish a healthy gut microbiome in newborns fed breast milk (or HMOs in formula) by fully digesting human milk oligosaccharides (HMOs), supporting immune development and reducing colic, gas, and diaper rash.

Product overview

Evivo is a specialized infant probiotic company offering two product formats—Evivo Drops and Evivo Powder Packets—both containing the proprietary B. infantis EVC001 strain. The products are designed to work synergistically with breast milk (or HMOs in formula) to establish a healthy gut microbiome in newborns and support immune function. Both products serve the same core purpose of delivering B. infantis EVC001 to infant guts, differentiated only by delivery format (liquid drops vs. powder).

Differentiator

Problem solved

Functional benefit

Products and services

• Evivo Drops A daily infant probiotic in liquid drop form containing the proprietary B. infantis EVC001 strain, designed for newborns fed any amount of breast milk (or HMOs found in formula) to help establish a protective gut microbiome and support healthy immune function. Made with Olive Oil and Organic Vitamin D3.
• Evivo Powder Packets A daily probiotic powder with B. infantis EVC001 in individually packaged sachets, available in cartons of 7 packets (each packet = 1 day supply). For newborns fed any amount of breast milk or HMOs found in formulas or HMO powder.

Quantifiable outcome

• 72% of parents saw reduced diaper rash; 63% observed less gas and fussiness; 52% reported longer sleep
• +6 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• Johnson & Johnson Consumer Inc.coreStrategic or Co-development PartnerClinical trial collaboration in Finland investigating the clinical and immunological effects of supplementation with live B. infantis strain in healthy breastfed infants. Study enrolled over 270 infants to assess impact on infant microbiome and immune health.
• Global Platform for the Prevention of Autoimmune Diabetes (GPPAD)coreStrategic or Co-development PartnerSINT1A Trial - randomized, placebo-controlled primary-prevention trial evaluating whether daily EVC001 supplementation during first year of life can reduce risk of developing type 1 diabetes-related autoimmunity. Enrolled 1,149 infants across several European countries and UK - the largest study to date investigating how an infant probiotic strain may influence autoimmune disease risk.
• Clean Label Project Baby CoalitionminorStrategic or Co-development PartnerCoalition of 30+ global CEOs from top baby, child, and maternal health brands dedicated to educating consumers, retailers, and medical communities on risks of environmental and industrial contaminant exposure to infants. Coalition advocates for progressive legislative and policy issues related to infant and maternal health.
• FORESITE 360minorGTM or Marketing PartnerPartnership for genomic testing recommendations. FORESITE 360 offers 100% whole genome sequencing for newborns and infants addressing disease pre-disposition and medication allergies. Evivo recommends this genomic test as complementary to infant gut health support.
• Tiny HealthminorGTM or Marketing PartnerGut microbiome testing partnership offering baby gut health tests that measure microbes in baby's stool. Evivo references this test to help parents determine gut imbalances and promotes with discount code EVIVO20.
• SimpliFedminorGTM or Marketing PartnerLactation professional organization providing breastfeeding support and education. SimpliFed helps families with breastfeeding after cesarean section and other feeding challenges. Evivo recommended as supplement to work with breast milk.

Scale indicators6 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Gerber (Nestle Nutrition): Mass-market infant nutrition brand (Nestle) offering Good Start SoothePro formula with probiotics and a full infant feeding portfolio. Overlaps on infant gut-health positioning and HCP endorsement but operates at vastly larger scale and broader product breadth.
• Plum Organics: Organic baby food, snack and meal brand (Campbell Soup) with national retail and DTC distribution. Adjacent comparable on organic/clean-label positioning, parent demographic, and baby-stage product portfolio breadth competing for the same household wallet.
• Mead Johnson (Enfamil / Reckitt): Global infant formula leader (Enfamil) now part of Reckitt, with bioactive and probiotic-positioned variants. Broad incumbent with pediatrician relationships and nationwide hospital sampling programs that Evivo competes against for recommendation-driven demand.

Emerging players

• Else Nutrition: Plant-based, clean-label toddler and infant nutrition brand distributed through DTC and natural channels. Comparable on clean-label/premium positioning, parent-of-toddler target, and natural-channel retail partnerships, though focused on whole-food formula alternatives.
• Bobbie: US-based DTC organic infant formula brand raising institutional capital. Comparable on DTC-first go-to-market, parent demographic, subscription mechanics, and premium positioning, though Bobbie focuses on formula rather than standalone probiotics.
• ByHeart: US DTC next-generation infant nutrition company offering whole-milk formula with clinically studied ingredients. Comparable on premium DTC positioning, parent target, and science-forward brand narrative competing for the same shelf space and pediatric recommendation slots.

Direct peers

• Culturelle: Probiotic brand owned by i-Health (Chr. Hansen) selling LGG-strain products including Kids and Baby formulations through mass-market retail and pediatrician sampling. Directly comparable on probiotic category, parent target, retail/DTC distribution, and HCP endorsement strategy.
• BioGaia: Swedish probiotics company selling B. lactis-based drops and tablets for infants and children through global distribution. Closest direct comparable: comparable target customer (parents of infants), probiotic drops format, healthcare-professional channel, and proprietary strain-led branding strategy.
• Wellements: Premium natural-organic baby wellness brand selling probiotics, gripe water, and supplements DTC and through natural retailers. Comparable target consumer (natural-leaning new parents), similar DTC-led distribution model, and overlapping product categories including infant probiotics.
• Biocodex (Florastor): French pharma-owned probiotics brand selling Saccharomyces boulardii-based products through pharmacies and DTC. Comparable on proprietary-strain-led differentiation, healthcare-provider recommendation channel, and probiotics-only focus.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

• Xx.com/evivo_health
• Facebookfacebook.com/EvivoHealth
• LinkedInlinkedin.com/company/evivo-health

Revenue estimate

Valuation estimate

Number of profiles

Profiles13 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Evivo